The Discounted Cash Flow (DCF) valuation of Generic Sweden AB (publ) (GENI.ST) is 66.59 SEK. With the latest stock price at 47.65 SEK, the upside of Generic Sweden AB (publ) based on DCF is 39.8%.
Based on the latest price of 47.65 SEK and our DCF valuation, Generic Sweden AB (publ) (GENI.ST) is a buy. buying GENI.ST stocks now will result in a potential gain of 39.8%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.1% | 6.2% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 48.16 - 114.10 | 66.59 |
| Upside | 1.1% - 139.5% | 39.8% |